Sean Aylmer, Michael Thompson and Adam Lang each nominate their top international story from the year - and choose a winner.

Sean Aylmer, Michael Thompson and Adam Lang each nominate their top international story from the year - and choose a winner.

Daily business news for people who make their own decisions, with business journalist Sean Aylmer and Michael Thompson. Find out more at https://fearandgreed.com.au

Daily business news for people who make their own decisions, with business journalist <a href="https://www.linkedin.com/in/sean-aylmer-9922068/" data-saferedirecturl="https://www.google.com/url?q=https://www.linkedin.com/in/sean-aylmer-9922068/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw0wu3ezGEfBZFYspJbTTaYL">Sean Aylmer</a> and <a href="https://www.linkedin.com/in/mcwthompson/" data-saferedirecturl="https://www.google.com/url?q=https://www.linkedin.com/in/mcwthompson/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw08pZ8jZ88rHJgCfbHkTr5k">Michael Thompson</a>. Find out more at <a href="https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain=fearandgreed.com.au/" data-saferedirecturl="https://www.google.com/url?q=https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain%3Dfearandgreed.com.au/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw1DLq_FuqjEt3HC-ZK1704H">https://fearandgreed.com.au</a>

Fear and Greed is Australia's most popular business podcast.

FEAR & GREED | Business News

Daily business news for people who make their own decisions, with business journalist <a href="https://www.linkedin.com/in/sean-aylmer-9922068/">Sean Aylmer</a> and <a href="https://www.linkedin.com/in/mcwthompson/">Michael Thompson</a>. Find out more at <a href="https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain=fearandgreed.com.au/">https://fearandgreed.com.au</a>

Global elections vs China's slowdown vs return of Trump

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/6a921c95-c2f0-458f-9aac-b24c007d2598/transcript

Logistics company Brambles, glass bottle manufacturer Orora and waste business Cleanaway - three very different companies, but three fascinating stories. 

Jakob Cakarnis, Director of Equity Research at Jarden Australia, tells Sean Aylmer what he likes and dislikes about them.

This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.

Logistics company Brambles, glass bottle manufacturer Orora and waste business Cleanaway - three very different companies, but three fascinating stories. Jakob Cakarnis, Director of Equity Research at Jarden Australia, tells Sean Aylmer what he likes and dislikes about them. This is Fear &amp; Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.

Three mid-cap stocks to consider

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/abd0df5d-0d83-4a3b-84b0-b24c007d0226/transcript

Sean Aylmer, Michael Thompson and Adam Lang each nominate their top markets story from the year - and choose a winner.

Sean Aylmer, Michael Thompson and Adam Lang each nominate their top markets story from the year - and choose a winner.

Sharemarket records vs end of Magnificent 7 vs Bitcoin booming

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/c37b0735-d9f2-4bd3-b532-b24c007cc408/transcript

Guest: Mesoblast founder Silviu Itescu

Original air date: March 9, 2022

ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.

 

Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.

Update: Mesoblast's share price increased by 50% in just one day this week after the US FDA gave the green light to another one of its treatments. 

Guest: Mesoblast founder Silviu Itescu
Original air date: March 9, 2022
ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.
&nbsp;
Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.
Update: Mesoblast's share price increased&nbsp;by 50% in just one day this week after the&nbsp;US FDA gave the green light to another one of its&nbsp;treatments.&nbsp;

Sunday feature: This Aussie company's share price is up 900% this year

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/00445315-d697-45ad-b67a-b24c0079323d/transcript

Global elections vs China's slowdown vs return of Trump

In 1 playlist(s)

FEAR & GREED | Business News

Social links

Follow podcast

Recent clips